Global and regional amyloid-β in explaining APOE-ε4 and sex associations with medial temporal tau: a neuropathology study
Abstract The medial temporal lobe (MTL) is a key region in Alzheimer’s disease (AD) pathogenesis, affected early by tau pathology. While female sex and APOE-ε4 are two known risk factors that affect tau levels, whether these factors drive tau in the MTL via amyloid-dependent or amyloid-independent mechanisms remains unclear. We investigated these relationships in two large neuropathological cohorts comprising 2550 participants from the Religious Orders Study/Memory and Aging Project (ROS/MAP; n =1587, main cohort) and Arizona Study of Aging and Neurodegenerative Disorders (AZSAND; n=963, replication cohort) covering the whole AD continuum. Neuropathological assessments of global neocortical and regional MTL amyloid-β burden were used to determine the extent to which amyloid-β pathology mediated associations of APOE-ε4 carriership and sex with MTL tau burden. In both cohorts, APOE-ε4 carriership and female sex were associated with significantly greater MTL tau pathology (all p <0.001). Adjustment for global amyloid-β attenuated but did not eliminate these associations ( p ≤0.024). However, after jointly accounting for global and MTL amyloid-β burden, the association between APOE-ε4 and MTL tau was no longer significant in either cohort ( p ≥0.19), whereas the association between female sex and MTL tau remained robust ( p ≤0.004). Models incorporating both global and regional MTL amyloid-β explained substantially more variance in MTL tau burden than models including only global amyloid-β, and results were replicated when further adjusting for diagnostic group or neocortical tau burden. These findings suggest that APOE-ε4 and female sex influence MTL tau accumulation through partially distinct pathogenic pathways, supporting an additional contribution of regional amyloid-β to the APOE-ε4-associated MTL tau burden while implicating additional amyloid-independent mechanisms in female vulnerability to tau accumulation.
Authors
- Rik Ossenkoppele (ORCID: https://orcid.org/0000-0003-1584-7477)
- Julie A. Schneider (ORCID: https://orcid.org/0000-0003-0756-5007)
- Eric M. Reiman (ORCID: https://orcid.org/0000-0002-0705-3696)
- Geidy E. Serrano (ORCID: https://orcid.org/0000-0002-9527-2011)
- Laura E.M. Wisse (ORCID: https://orcid.org/0000-0001-7504-3943)
- Gemma Salvadó (ORCID: https://orcid.org/0000-0002-5210-9230)
- Colin Groot (ORCID: https://orcid.org/0000-0002-5802-6946)
- Jacob W. Vogel (ORCID: https://orcid.org/0000-0001-6394-9940)
- Oskar Hansson
- Thomas G. Beach
- David A. Bennett
Institutions
- Rush University Medical Center (US)
- University of Arizona (US)
- Lund University (SE)
- Science for Life Laboratory (SE)
- Pasqual Maragall Foundation (ES)
- Amsterdam Neuroscience (NL)
- Barcelonaβeta Brain Research Center (ES)
- Skåne University Hospital (SE)
- Banner Sun Health Research Institute (US)
- Centro de Investigación Biomédica en Red de Fragilidad y Envejecimiento Saludable (ES)
- Hospital del Mar Research Institute (ES)
- Banner Alzheimer’s Institute
- Arizona State University (US)
Publication Details
- Journal
- Acta Neuropathologica
- Published
- 2026-10-09
- DOI
- https://doi.org/10.1007/s00401-026-03095-2
- Primary Topic
- Alzheimer's disease research and treatments
- Type
- article
- Field-Weighted Citation Impact
- 0.00